Population-based survival-cure analysis of ER-negative breast cancer

By Huang Lan  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 257-264

Springer Publishing Company

Access to resources Recommend Favorite

EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer

By Dubsky P.   Filipits M.   Jakesz R.   Rudas M.   Singer C. F.   Greil R.   Dietze O.   Luisser I.   Klug E.   Sedivy R.   Bachner M.   Mayr D.   Schmidt M.   Gehrmann M. C.   Petry C.   Weber K. E.   Kronenwett R.   Brase J. C.   Gnant M.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 640-647

Oxford University Press

Access to resources Recommend Favorite

Involvement of ER-α36, Src, EGFR and STAT5 in the biphasic estrogen signaling of ER-negative breast cancer cells

By        

Oncology Reports, Vol. 27, Iss. 6, 2012-01 ,pp. : 2057-2065

Spandidos Publications

Access to resources Recommend Favorite

Is the Negative Prognostic Value of High Oestrogen Receptor (ER) Levels in Postmenopausal Breast Cancer Patients Due to a Modified ER Gene Product?

By Sancho-Garnier H.   Delarue J.-C.   Mouriesse H.   Contesso G.   May-Levin F.   Gotteland M.   May E.  

European Journal of Cancer, Vol. 31, Iss. 11, 1995-10 ,pp. : 1851-1855

Elsevier

Access to resources Recommend Favorite

EGFR over-expression and activation in high HER2, ER negative breast cancer cell line induces trastuzumab resistance

By Dua Rajiv  

Breast Cancer Research and Treatment, Vol. 122, Iss. 3, 2010-08 ,pp. : 685-697

Springer Publishing Company

Access to resources Recommend Favorite